Topics: Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs | Vaccines 2.0 - developing the next generation of vaccines | Development of new effective therapies for rare diseases
Deadline 1. Stufe: 01.02.2022
Deadline 2. Stufe: 06.09.2022
HORIZON-HLTH-2022-DISEASE-06-02-two-stage:
Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs (RIA)
♦ Cross-cutting priorities: Clinical Studies, SSH
HORIZON-HLTH-2022-DISEASE-06-03-two-stage:
Vaccines 2.0 - developing the next generation of vaccines (RIA)
♦ Cross-cutting priorities: Clinical Studies, International Cooperation, SSH
HORIZON-HLTH-2022-DISEASE-06-04-two-stage:
Development of new effective therapies for rare diseases (RIA)
♦ Cross-cutting priorities: Clinical Studies, International Cooperation, SSH, EOSC and FAIR data
